STOCK TITAN

Sight Sciences ex-officer plans sale of 12,219 shares

Sight Sciences, Inc. (SGHT) is the issuer for a Rule 144 notice filed for the account of former officer Jeremy B. Hayden covering planned sales of common stock.

(Neutral)
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Sight Sciences, Inc. (SGHT) is the issuer for a Rule 144 notice filed for the account of former officer Jeremy B. Hayden covering planned sales of common stock. The notice lists 12,219 shares of common stock to be sold, associated with restricted stock vesting on August 31, 2026, held in an account at Fidelity Brokerage Services LLC.

The filing also lists several prior sales of Sight Sciences common stock by Jeremy Hayden during the past three months, each with its own date, share amount, and aggregate sale price. The notice is signed on September 4, 2026, by Jessica Spraker as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Jeremy Hayden.

Positive

  • None.

Negative

  • None.
Shares to be sold under Rule 144 12,219 shares Common stock tied to restricted stock vesting dated August 31, 2026
Largest single recent sale amount 48,000 shares Common stock sold on August 14, 2026 for $395,880.00
Sale on July 6, 2026 12,733 shares for $70,132.10 Common stock of Sight Sciences sold by Jeremy Hayden
Sale on August 11, 2026 20,918 shares for $165,878.62 Common stock sold by Jeremy Hayden
Sale on September 1, 2026 13,253 shares for $109,974.72 Common stock sold by Jeremy Hayden
Planned sale date for vested shares August 31, 2026 Date tied to restricted stock vesting for the 12,219 shares
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Restricted Stock Vesting financial
"Common | 08/31/2026 | Restricted Stock Vesting | Issuer"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
attorney-in-fact regulatory
"as attorney-in-fact for Jeremy Hayden."
An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

What does the Form 144 filing disclose for Sight Sciences, Inc. (SGHT)?

The Form 144 discloses that Jeremy B. Hayden, a former officer, has filed a notice of proposed sale under Rule 144 for 12,219 shares of Sight Sciences common stock related to restricted stock vesting on August 31, 2026.

How many Sight Sciences (SGHT) shares are planned to be sold under this Form 144?

The notice covers a proposed sale of 12,219 shares of Sight Sciences common stock. These shares are tied to restricted stock vesting on August 31, 2026 and are held at Fidelity Brokerage Services LLC.

Who is the person selling Sight Sciences (SGHT) shares under Rule 144?

The person for whose account the securities are to be sold is Jeremy B. Hayden, identified as a former officer of Sight Sciences, Inc. The filing gives his Menlo Park, California address as the contact location.

What prior sales of Sight Sciences (SGHT) shares are reported in the past three months?

The filing lists multiple sales of Sight Sciences common stock by Jeremy Hayden between July 6, 2026 and September 1, 2026, each with specific share amounts and aggregate prices, including transactions such as 48,000 shares for $395,880.00 on August 14, 2026.

Where are the Sight Sciences (SGHT) shares held for the planned Rule 144 sale?

The shares for the planned sale are common stock of Sight Sciences held at Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, Rhode Island, as stated in the securities information section of the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading